- id: q1
  question: >-
    Which proteomic experiments in CKG report elevated EGFR expression in colon
    cancer, and what PubMed literature supports the functional relevance?
  expected_context:
    - Protein:EGFR
    - Disease:Colon Cancer

- id: q2
  question: >-
    Summarize pathways and findings from CKG experiments that implicate BRAF
    V600E dysregulation and cite supporting PubMed articles.
  expected_context:
    - Protein:BRAF
    - Pathway:MAPK signaling

- id: q3
  question: >-
    Identify interacting proteins for NRAS uncovered in CKG and highlight
    PubMed evidence discussing resistance mechanisms to targeted inhibitors.
  expected_context:
    - Protein:NRAS
    - Interaction:Protein
- id: demo-01
  question: >-
    Which targeted therapies are supported by CIVIC evidence for BRAF V600E
    variants, and which TCGA samples show matching variants?
  expected_context:
    - Gene:BRAF
    - Variant:V600E
    - Disease:Melanoma

- id: demo-02
  question: >-
    Summarize EGFR expression patterns in CPTAC RNA-seq data and link relevant
    PubMed literature mentions supporting therapeutic relevance in colorectal
    cancer.
  expected_context:
    - Gene:EGFR
    - Disease:Colorectal Cancer

- id: demo-03
  question: >-
    What resistance mechanisms involving NRAS Q61 mutations appear in CIVIC
    evidence and PubMed literature, and how do they connect to MEK inhibitors?
  expected_context:
    - Gene:NRAS
    - Variant:Q61
    - Drug:MEK inhibitor



